Latest Breaking News On - Shape lifesciences investor contact - Page 2 : comparemela.com

ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering

ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
New-york
America
Michael-miller
Thomas-stankovich
Maxim-group
Exchange-commission
Nasdaq
Rx-communications-group
Reshape-marketplace
Diabetes-bloc-stim-neuromodulation
Private-securities-litigation-reform-act

ReShape Lifesciences Inc. (RSLS) Enters Exclusive License Agreement With Biorad Medisys for Obalon Gastric Balloon System

ReShape Lifesciences Inc. (RSLS) Enters Exclusive License Agreement With Biorad Medisys for Obalon Gastric Balloon System
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sri-lanka
India
Pakistan
Maldives
United-states
Bangladesh
Nepal
Mumbai
Maharashtra
America
Biorad-medysis
Thomas-stankovich

ReShape Lifesciences Inc: ReShape Lifesciences Signs Exclusive License Agreement With Biorad Medisys for Obalon Gastric Balloon System

ReShape Lifesciences Inc: ReShape Lifesciences Signs Exclusive License Agreement With Biorad Medisys for Obalon Gastric Balloon System
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Steigen
Baden-wüberg
Germany
Nepal
India
Pakistan
United-states
Maldives
Mumbai
Maharashtra
Sri-lanka
Bangladesh

ReShape Lifesciences Signs Exclusive License Agreement With Biorad Medisys for Obalon Gastric Balloon System

21.09.2023 - Royalty-Bearing License Agreement Covers the Countries in the Indian Subcontinent, Representing Approximately 20% to 25% of the World’s PopulationIRVINE, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) - ReShape Lifesciences Inc. (Nasdaq: RSLS), the .

Thomas-stankovich
Paulf-hickey
Michael-miller
Drug-administration
Rx-communications-group
Exchange-commission
Obalon-balloon-system
Chief-executive-officer
South-asia
Obalon-system
Shape-lifesciences
Lap-band-system

ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System

Royalty-Bearing License Agreement Covers the Countries in the Indian Subcontinent, Representing Approximately 20% to 25% of the World’s PopulationIRVINE, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the signing of an exclusive, royalty-bearing license agreement with Biorad Medysis, Pvt. Ltd. (Biorad) to manufacture, commercialize and distribute the Obalon® Gastric

Pakistan
Sri-lanka
Maldives
India
United-states
Nepal
Bangladesh
Mumbai
Maharashtra
America
Paulf-hickey
Michael-miller